Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-17-001566
Filing Date
2017-02-21
Accepted
2017-02-21 10:00:34
Documents
8
Period of Report
2017-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp73083_6k.htm 6-K 20067
2 EXHIBIT 1.1 dp73083_ex0101.htm EX-1.1 294884
3 EXHIBIT 4.1 dp73083_ex0401.htm EX-4.1 95911
4 EXHIBIT 5.1 dp73083_ex0501.htm EX-5.1 65044
5 EXHIBIT 5.2 dp73083_ex0502.htm EX-5.2 10322
6 GRAPHIC image_001.jpg GRAPHIC 3871
7 GRAPHIC logo.jpg GRAPHIC 5849
8 GRAPHIC image_002.jpg GRAPHIC 2382
  Complete submission text file 0000950103-17-001566.txt   504374
Mailing Address FALKNERSTRASSE 4 4001 BASEL V8 00000
Business Address FALKNERSTRASSE 4 4001 BASEL V8 00000 41 (0)61 201 13 50
Auris Medical Holding AG (Filer) CIK: 0001601936 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 17623857
SIC: 2834 Pharmaceutical Preparations